GlassScriptPhysician profile
Eileen Zhuang
NPI 1881080745
$1,024.89
in general payments reported to CMS, 2019-2025
12 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.45 · 2023: $312 · 2024: $383 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $558.25 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $72.92 | 2022-2023 | |
| Grifols USA, LLC | $68.68 | 2023 | Xembify, Prolastin-C Liquid |
| Amgen INC. | $57.15 | 2024 | Tezspire |
| Insmed, INC. | $54.38 | 2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.63 | 2023-2024 | Ofev |
| Tactile Systems Technology INC | $42.88 | 2024 | Flexitouch Plus, Entre Plus |
| Takeda Pharmaceuticals U.S.A., INC. | $32.49 | 2023 | Glassia |
| Astrazeneca Pharmaceuticals LP | $27.82 | 2025 | Airsupra |
| Harmony Biosciences LLC | $25.00 | 2023 | Wakix |
| Jazz Pharmaceuticals INC. | $20.79 | 2023 | Xywav |
| Axsome Therapeutics, INC. | $12.90 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Zhuang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.